Although FcRn has garnered robust scientific attention [18], its expression in cancer cells and feasibility as a prognostic factor have only been studied in limited types of malignancies, such as non-small cell lung cancer and rectal cancer [19,20]. Here, FCGRT is linked to non-small cell lung carcinoma.